Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0240066 (
iron deficiency
)
7,156
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adenosine triphosphate (ATP) and adenosine diphosphate levels are decreased in erythrocytes from individuals with beta-thalassemia minor. Because 5-phosphoribosyl-1-pyrophosphate (PRPP) is an essential precurosr of adenine nucleotides, we tested the hypothesis that impaired PRPP synthesis is a mechanism for the decreased adenine nucleotide content. Erythrocyte
PRPP synthetase
activity was significantly decreased, and the Michaelis-Menten constant (Km) for ribose-5-phosphate (R5P) was significantly increased in individuals with alpha-thalassemia minor and those with beta-thalassemia minor. Intact erythrocytes from individuals with alpha-thalassemia and those with beta-thalassemia minor also had an impaired rate of PRPP formation. Both the decrease in
PRPP synthetase
activity and the impaired PRPP formation were also found in erythrocytes with microcytosis resulting from
iron deficiency
, indicating that these phenomena may not be specific to thalassemia minor. In all individuals examined, the rate of PRPP formation correlated with ATP content, suggesting that either (1)
PRPP synthetase
activity is a determinant of ATP content or (2) ATP content is a determinant of
PRPP synthetase
activity. The depletion of ATP from normal erythrocytes did not affect
PRPP synthetase
activity, suggesting that ATP content is not a determinant of
PRPP synthetase
activity. However, a decrease in
PRPP synthetase
activity did cause an impairment in the rate of adenine nucleotide synthesis, suggesting that
PRPP synthetase
activity is a determinant of ATP content. Taken together, our results suggest that the decrease in
PRPP synthetase
activity and the resulting impairment in the rate of PRPP formation are mechanisms for the decreased adenine nucleotide content in thalassemic erythrocytes.
...
PMID:Decreased erythrocyte phosphoribosylpyrophosphate synthetase activity and impaired formation in thalassemia minor: a mechanism for decreased adenine nucleotide content. 254 52